RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase

Cancer Research

Volumn 67, Issue 21, 2007, Pages 10317-10324

  Scuto, Anna ^a   Zhang, Hongling ^b   Zhao, Haiyan ^b   Rivera, Maria ^b   Yeatman, Timothy J ^b   Jove, Richard ^a   Torres Roca, Javier F ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; F ACTIN; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN RABP48; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CELL NUCLEUS; CELL SHAPE; CELL SIZE; CELL STRAIN 3T3; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS FIBER;

3T3 CELLS; ACTINS; ANIMALS; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CYTOSKELETON; FEMALE; FOCAL ADHESIONS; GENES, RAS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; NUCLEAR PROTEINS; PAXILLIN; RNA, SMALL INTERFERING;

EID: 35948943847     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3313     Document Type: Article

References (48)

1. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory-protein family of WD-repeat proteins. Nature 1994;371:297-300.
2. Qian YW, Wang YC, Hollingsworth RE, Jr., Jones D, Ling N, Lee EY. A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature 1993;364:648-52.
3. Qian Y-W, Lee EYHP. Dual retinoblastoma-binding proteins with properties related to a negative regulator of Ras in yeast. J Biol Chem 1995;270:25507-13.
4. Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 1996;272:408-11.
5. Nicolas E, Morales V, Magnaghi-Jaulin L, Harel-Bellan A, Richard-Foy H, Trouche D. RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein. J Biol Chem 2000;275:9797-804.
6. Henikoff S. Gene regulation Versatile assembler. Nature 2003;423:814-7.
7. Wolffe AP, Urnov FD, Guschin D. Co-repressor complexes and remodellingchroma tin for repression. Biochem Soc Trans 2000;28:379-86.
8. Urnov FD, Wolffe AP, Guschin D. Molecular mechanisms of corepressor function. Curr Top Microbiol Immunol 2001;254:1-33.
9. Furuyama T, Tie F, Harte PJ. Polycomb group proteins ESC and E(Z) are present in multiple distinct complexes that undergo dynamic changes during development. Genesis 2003;35:114-24.
10. Muller J, Hart CM, Francis NJ, et al. Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 2002;111:197-208.
11. Verreault A, Kaufman PD, Kobayashi R, Stillman B. Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4. Cell 1996;87:95-104.
12. Narlikar GJ, Fan H-Y, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002;108:475-87.
13. Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, Wolffe AP. Mi-2 complex couples DNA methylation to chromatin remodellingand histone deacetylation. Nat Genet 1999;23:62-6.
14. Wade PA, Jones PL, Vermaak D, Wolffe AP. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Curr Biol 1998;8:843-6.
15. Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodelingand histone deacetylase activities. Mol Cell 1998;2:851-61.
16. Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998;95:279-89.
17. Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 1998;395:917-21.
18. Parthun MR, Widom J, Gottschling DE. The major cytoplasmic histone acetyltransferase in yeast: links to chromatin replication and histone metabolism. Cell 1996;87:85-94.
19. Verreault A, Kaufman PD, Kobayashi R, Stillman B. Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase. Curr Biol 1998;8:96-108.
20. Hennig L, Taranto P, Walser M, Schonrock N, Gruissem W. Arabidopsis MSI1 is required for epigenetic maintenance of reproductive development. Development 2003;130:2555-65.
21. Lu X, Horvitz HR. lin-35 and lin-53, two genes that antagonize a C. elegans Ras pathway, encode proteins similar to Rb and its bindingprotein RbAp48. Cell 1998;95:981-91.
22. Ruggieri R, Tanaka K, Nakafuku M, Kaziro Y, Toh-e A, Matsumoto K. MSI1, a negative regulator of the RAS-cAMP pathway in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 1989;86:8778-82.
23. Cox AD, Der CJ. The dark side of Ras: regulation of apoptosis. Oncogene 2003;22:8999-9006.
24. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding Ras: "it ain't over 'til it's over." Trends Cell Biol 2000;10:147-54.
25. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003;3:11-22.
26. Hancock JF. Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol 2003;4:373-84.
27. Bar-Sagi D, Hall A. Ras and Rho GTPases: a family reunion. Cell 2000;103:227-38.
28. Gupta AK, Bakanauskas VJ, Cerniglia GJ, et al. The Ras radiation resistance pathway. Cancer Res 2001;61:4278-82.
29. Tang Y, McKenna WG, Muschel RJ, Gupta AK, Hahn SM, Bernhard EJ. The RAS signal transduction pathway and its role in radiation sensitivity. Oncogene 2003;22:5866-75.
30. Kim IA, Fernandes AT, Gupta AK, McKenna WG, Bernhard EJ. The influence of Ras pathway signaling on tumor radiosensitivity. Cancer Metastasis Rev 2004;23:227-36.
31. Torres-Roca JF, Eschrich S, Zhao H, et al. Prediction of radiation sensitivity usinga gene expression classifier. Cancer Res 2005;65:7169-76.
32. Bar-Sagi D, Feramisco JR. Induction of membrane rufflingand fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 1986;233:1061-8.
33. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992;70:389-99.
34. Rodriguez-Viciana P, Warne PH, Khwaja A, et al. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 1997;89:457-67.
35. Zhong C, Kinch MS, Burridge K. Rho-stimulated contractility contributes to the fibroblastic phenotype of Ras-transformed epithelial cells. Mol Biol Cell 1997;8:2329-44.
36. Zondag GCM, Evers EE, ten Klooster JP, Janssen L, van der Kammen RA, Collard JG. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J Cell Biol 2000;149:775-82.
37. Pawlak G, Helfman DM. Post-transcriptional downregulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. Mol Biol Cell 2002;13:336-47.
38. Hannigan G, Troussard AA, Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 2005;5:51-63.
39. Wu C, Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 2001;155:505-10.
40. Pawlak G, Helfman DM. MEK mediates v-Src-induced disruption of the actin cytoskeleton via inactivation of the Rho-ROCK-LIM kinase pathway. J Biol Chem 2002;277:26927-33.
41. Sondek J, Bohm A, Lambright DG, Hamm HE, Sigler PB. Crystal structure of a G-protein βγ dimer at 2.1A resolution. Nature 1996;379:369-74.
42. Elad-Sfadia G, Haklai R, Balan E, Kloog Y. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J Biol Chem 2004;279:34922-30.
43. Sahai E, Olson MF, Marshall CJ. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J 2001;20:755-66.
44. Reuveni H, Geiger T, Geiger B, Levitzki A. Reversal of the Ras-induced transformed phenotype by HR12, a novel Ras farnesylation inhibitor, is mediated by the Mek/Erk pathway. J Cell Biol 2000;151:1179-92.
45. Voice JK, Klemke RL, Le A, Jackson JH. Four human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J Biol Chem 1999;274:17164-70.
46. Yan J, Roy S, Apolloni A, Lane A, Hancock JF. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem 1998;273:24052-6.
47. Choi J-A, Park M-T, Kang C-M, et al. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Oncogene 2004;23:9-20.
48. Pollock CB, Shirasawa S, Sasazuki T, Kolch W, Dhillon AS. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Cancer Res 2005;65:1244-50.